5-13692170-A-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001369.3(DNAH5):c.13724-35T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.544 in 1,611,270 control chromosomes in the GnomAD database, including 239,576 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.55 ( 22763 hom., cov: 31)
Exomes 𝑓: 0.54 ( 216813 hom. )
Consequence
DNAH5
NM_001369.3 intron
NM_001369.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.192
Publications
11 publications found
Genes affected
DNAH5 (HGNC:2950): (dynein axonemal heavy chain 5) This gene encodes a dynein protein, which is part of a microtubule-associated motor protein complex consisting of heavy, light, and intermediate chains. This protein is an axonemal heavy chain dynein. It functions as a force-generating protein with ATPase activity, whereby the release of ADP is thought to produce the force-producing power stroke. Mutations in this gene cause primary ciliary dyskinesia type 3, as well as Kartagener syndrome, which are both diseases due to ciliary defects. [provided by RefSeq, Oct 2009]
DNAH5 Gene-Disease associations (from GenCC):
- primary ciliary dyskinesia 3Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, ClinGen
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 5-13692170-A-T is Benign according to our data. Variant chr5-13692170-A-T is described in ClinVar as Benign. ClinVar VariationId is 258001.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.557 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| DNAH5 | ENST00000265104.5 | c.13724-35T>A | intron_variant | Intron 78 of 78 | 1 | NM_001369.3 | ENSP00000265104.4 | |||
| DNAH5 | ENST00000681290.1 | c.13679-35T>A | intron_variant | Intron 78 of 78 | ENSP00000505288.1 | |||||
| DNAH5 | ENST00000683611.1 | n.1057-35T>A | intron_variant | Intron 4 of 4 |
Frequencies
GnomAD3 genomes AF: 0.545 AC: 82803AN: 151900Hom.: 22737 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
82803
AN:
151900
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.523 AC: 128841AN: 246408 AF XY: 0.518 show subpopulations
GnomAD2 exomes
AF:
AC:
128841
AN:
246408
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.543 AC: 793072AN: 1459252Hom.: 216813 Cov.: 33 AF XY: 0.540 AC XY: 391790AN XY: 725950 show subpopulations
GnomAD4 exome
AF:
AC:
793072
AN:
1459252
Hom.:
Cov.:
33
AF XY:
AC XY:
391790
AN XY:
725950
show subpopulations
African (AFR)
AF:
AC:
18527
AN:
33410
American (AMR)
AF:
AC:
22693
AN:
44610
Ashkenazi Jewish (ASJ)
AF:
AC:
14127
AN:
26094
East Asian (EAS)
AF:
AC:
16223
AN:
39542
South Asian (SAS)
AF:
AC:
37591
AN:
86118
European-Finnish (FIN)
AF:
AC:
28848
AN:
53296
Middle Eastern (MID)
AF:
AC:
2915
AN:
5652
European-Non Finnish (NFE)
AF:
AC:
619859
AN:
1110228
Other (OTH)
AF:
AC:
32289
AN:
60302
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
18243
36486
54729
72972
91215
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
17376
34752
52128
69504
86880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.545 AC: 82891AN: 152018Hom.: 22763 Cov.: 31 AF XY: 0.540 AC XY: 40112AN XY: 74332 show subpopulations
GnomAD4 genome
AF:
AC:
82891
AN:
152018
Hom.:
Cov.:
31
AF XY:
AC XY:
40112
AN XY:
74332
show subpopulations
African (AFR)
AF:
AC:
23339
AN:
41438
American (AMR)
AF:
AC:
8005
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
1926
AN:
3470
East Asian (EAS)
AF:
AC:
2319
AN:
5158
South Asian (SAS)
AF:
AC:
2115
AN:
4820
European-Finnish (FIN)
AF:
AC:
5768
AN:
10582
Middle Eastern (MID)
AF:
AC:
154
AN:
292
European-Non Finnish (NFE)
AF:
AC:
37561
AN:
67958
Other (OTH)
AF:
AC:
1168
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1947
3895
5842
7790
9737
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
720
1440
2160
2880
3600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1674
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Nov 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Primary ciliary dyskinesia 3 Benign:2
Jun 15, 2021
Pars Genome Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.